These effects were associated with the upregulation of the genes of COX-1 and COX-2 proteins and the EMT marker genes VIM and TWIST1 in colorectal tumor tissue vs. predrug (baseline) (Figures 8A, 9A; Supplementary Figure S4A). The gene discussed is PTGS2; the disease is colorectal neoplasm.